FGF21 and metabolic dysfunction-associated steatotic liver disease: In addition, studies have shown that NF-κB negatively regulates FGF21 transcription by directly binding to its promoter DNA, and FGF21 can promote the transition of NAFLD to HCC through the NF-κB pathway [21].